Filing Details

Accession Number:
0001567619-21-012496
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-22 18:07:57
Reporting Period:
2021-06-22
Accepted Time:
2021-06-22 18:07:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1533743 Processa Pharmaceuticals Inc. PCSA Pharmaceutical Preparations (2834) 451539785
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1828217 Michael Robert Floyd C/O Processa Pharmaceuticals, Inc.
7380 Coca Cola Drive, Suite 106
Hanover MD 21076
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-22 2,000 $7.03 28,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 103,851 Indirect by Elion Oncology, Inc.